News | January 07, 2023
Dabur India expects low to mid-single digit revenue growth for Q3 FY23
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
The Government of India is supporting the states in active case detection, surveillance, treatment, supply of diagnostic kits, medicines, sprays etc.
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
The company is one of the most profitable companies manufacturing speciality chemicals in India
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
Modi stressed the need to ensure that the entire Covid infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes, and human resources
Subscribe To Our Newsletter & Stay Updated
